Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „setting“
Suchtreffer
Begriffe & Kennungen
Ituxredi · 4.8 · In the post marketing setting, serious viral infections have been reported in RA patients treated with rituxim
Eintrag öffnenLibtayo · 4.8 · The safety profile of cemiplimab in the adjuvant setting in the C-POST study is consistent with the known safe
Eintrag öffnenLuxturna · 4.8 · Following reports of chorioretinal atrophy in the post-marketing setting, a retrospective review of fundus pho
Eintrag öffnenMabThera · 4.8 · In the post marketing setting, serious viral infections have been reported in GPA/MPA patients treated with ri
Eintrag öffnenMabThera · 4.8 · In the post marketing setting, serious viral infections have been reported in PV patients treated with rituxim
Eintrag öffnenMabThera · 4.8 · In the post marketing setting, serious viral infections have been reported in RA patients treated with rituxim
Eintrag öffnenMircera · 4.8 · Cases of thrombocytopenia have been reported from post-marketing setting. A slight decrease in platelet counts
Eintrag öffnenMvasi · 4.8 · Table 3. Adverse reactions reported in post-marketing setting
Eintrag öffnenMyozyme · 4.8 · A small number of patients (<1%) in clinical trials and in the commercial setting developed anaphylactic shock
Eintrag öffnenNeulasta · 4.8 · Cases of capillary leak syndrome have been reported in the post-marketing setting with G-CSF use. These have g
Eintrag öffnenNivestim · 4.8 · In clinical studies and the post-marketing setting pulmonary adverse effects including interstitial lung disea
Eintrag öffnenObodence · 4.8 · Drug-related hypersensitivity reactions In the post-marketing setting, rare events of drug-related hypersensit
Eintrag öffnenObodence · 4.8 · In the post-marketing setting, rare cases of severe symptomatic hypocalcaemia resulting in hospitalisation, li
Eintrag öffnenOrganisationsaufgaben
Eintrag öffnenOsenvelt · 4.8 · Drug related hypersensitivity reactions In the post-marketing setting, events of hypersensitivity, including r
Eintrag öffnenOsenvelt · 4.8 · In the post-marketing setting, severe symptomatic hypocalcaemia (including fatal cases) has been reported, wit
Eintrag öffnenOsenvelt · 4.8 · Musculoskeletal pain In the post-marketing setting, musculoskeletal pain, including severe cases, has been rep
Eintrag öffnenPerjeta · 4.8 · 8 In addition, ADRs reported in the post-marketing setting are included in Table 2. As Perjeta was used with t
Eintrag öffnenPhelinun · 4.8 · GvHD is a very common complication in the allogeneic HSCT setting. Up to ≈ 60% patients develop acute and/or c
Eintrag öffnenPoherdy · 4.8 · In addition, ADRs reported in the post-marketing setting are included in Table 2. As pertuzumab was used with
Eintrag öffnen